Entrada Therapeutics, Inc. (TRDA)
NASDAQ·Healthcare·Biotechnology
$12.84
-0.93%
Mkt Cap $483.53M
Next Earnings
In 9 daysThu, May 7, 2026
EPS Estimate
-$1.06
6 analysts
Revenue Estimate
$2.92M
Last quarter: beat by +28.79% on EPS, -82.47% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$483.53M
P/E
—
Fwd P/E
—
P/S
19.02
Rev TTM
—
EPS TTM
-$3.47